Sponsor:
Karyopharm Therapeutics Inc
Code:
NCT05611931
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
Matching Placebo for selinexor
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations